The Value of Source Data Verification in a Cancer Clinical Trial
暂无分享,去创建一个
Catrin Tudur Smith | John P. Neoptolemos | Janet Dunn | Trevor Cox | David Cunningham | J. Neoptolemos | D. Stocken | D. Cunningham | P. Ghaneh | J. Dunn | C. Tudur Smith | T. Cox | Deborah D. Stocken | Paula Ghaneh
[1] Anders Grahnén,et al. Quality assurance within the scope of Good Clinical Practice (GCP)—what is the cost of GCP-related activities? A survey within the Swedish Association of the Pharmaceutical Industry (LIF)'s members , 2009 .
[2] F. Hamdy,et al. A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance. , 2011, Journal of clinical epidemiology.
[3] P. Lachenbruch,et al. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. , 1999, Statistics in medicine.
[4] M. Buyse,et al. Impact of on-site initiation visits on patient recruitment and data quality in a randomized trial of adjuvant chemotherapy for breast cancer , 2006, Clinical trials.
[5] Sheena McCormack,et al. The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial , 2012, Clinical trials.
[6] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .
[7] M. van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.
[8] James D Neaton,et al. Monitoring the quality of conduct of clinical trials: a survey of current practices , 2011, Clinical trials.
[9] Eric L Eisenstein,et al. Reducing the costs of phase III cardiovascular clinical trials. , 2005, American heart journal.
[10] M Van Glabbeke,et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.
[11] Douglas G Altman,et al. Ensuring trial validity by data quality assurance and diversification of monitoring methods , 2008, Clinical trials.
[12] J B Vermorken,et al. Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group. , 2000, European journal of cancer.
[13] M. Landray,et al. Risk-adapted approaches to the management of clinical trials: guidance from the Department of Health (DH)/Medical Research Council(MRC)/Medicines and Healthcare Products Regulatory Agency (MHRA) Clinical Trials Working Group , 2011, Trials.
[14] S. Meredith,et al. MRC/DH/MHRA Joint Project Risk-adapted approaches to the management of clinical trials of investigational medicinal products , 2011 .